Short Interest in Nicox S.A. (OTCMKTS:NICXF) Declines By 98.8%

Nicox S.A. (OTCMKTS:NICXFGet Free Report) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 600 shares, a drop of 98.8% from the February 28th total of 48,900 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Approximately 0.0% of the company’s shares are sold short.

Nicox Price Performance

Shares of Nicox stock remained flat at $0.25 on Friday. The company’s fifty day moving average is $0.25 and its two-hundred day moving average is $0.31. Nicox has a 12 month low of $0.25 and a 12 month high of $0.28.

Nicox Company Profile

(Get Free Report)

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.

Featured Articles

Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.